[go: up one dir, main page]

BRPI0415232A - uso de xenÈnio com hipotermia para tratar asfixia neonatal - Google Patents

uso de xenÈnio com hipotermia para tratar asfixia neonatal

Info

Publication number
BRPI0415232A
BRPI0415232A BRPI0415232-8A BRPI0415232A BRPI0415232A BR PI0415232 A BRPI0415232 A BR PI0415232A BR PI0415232 A BRPI0415232 A BR PI0415232A BR PI0415232 A BRPI0415232 A BR PI0415232A
Authority
BR
Brazil
Prior art keywords
xenon
hypothermic
neonatal asphyxia
treat neonatal
asphyxia
Prior art date
Application number
BRPI0415232-8A
Other languages
English (en)
Inventor
Nicholas Peter Franks
Mervyn Maze
Original Assignee
Protexeon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34436835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0415232(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0323861A external-priority patent/GB0323861D0/en
Priority claimed from GB0418539A external-priority patent/GB0418539D0/en
Application filed by Protexeon Ltd filed Critical Protexeon Ltd
Publication of BRPI0415232A publication Critical patent/BRPI0415232A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"USO DE XENÈNIO COM HIPOTERMIA PARA TRATAR ASFIXIA NEONATAL". A presente invenção refere-se ao uso de xenónio na preparação de um medicamento para o tratamento de asfixia neonatal em um indivíduo neonatal, em que o referido medicamento é para uso em combinação com hipotermia.
BRPI0415232-8A 2003-10-10 2004-10-11 uso de xenÈnio com hipotermia para tratar asfixia neonatal BRPI0415232A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0323861A GB0323861D0 (en) 2003-10-10 2003-10-10 Use
GB0418539A GB0418539D0 (en) 2004-08-19 2004-08-19 Use
PCT/GB2004/004298 WO2005034966A1 (en) 2003-10-10 2004-10-11 Use of xenon with hypothermia for treating neonatal asphyxia

Publications (1)

Publication Number Publication Date
BRPI0415232A true BRPI0415232A (pt) 2006-12-12

Family

ID=34436835

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415232-8A BRPI0415232A (pt) 2003-10-10 2004-10-11 uso de xenÈnio com hipotermia para tratar asfixia neonatal

Country Status (13)

Country Link
US (1) US7390508B2 (pt)
EP (1) EP1670489B1 (pt)
JP (1) JP4880466B2 (pt)
AT (1) ATE380554T1 (pt)
AU (1) AU2004280118B2 (pt)
BR (1) BRPI0415232A (pt)
CA (1) CA2538104C (pt)
DE (1) DE602004010691T2 (pt)
DK (1) DK1670489T3 (pt)
ES (1) ES2298815T3 (pt)
MX (1) MXPA06003471A (pt)
PT (1) PT1670489E (pt)
WO (1) WO2005034966A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE380554T1 (de) * 2003-10-10 2007-12-15 Protexeon Ltd Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
GB0418540D0 (en) 2004-08-19 2004-09-22 Protexeon Ltd Use
GB0520176D0 (en) * 2005-10-04 2005-11-09 Imp College Innovations Ltd Use
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
AU2014277860A1 (en) * 2008-01-22 2015-01-22 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
CA2712516C (en) * 2008-01-22 2016-06-28 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
US9744142B2 (en) * 2009-05-05 2017-08-29 Board Of Regents, The University Of Texas Systems Formulations of volatile anesthetics and methods of use for reducing inflammation
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
JP6625966B2 (ja) 2013-03-15 2019-12-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 希ガスが豊富な液体ならびにその調製及び使用の方法
FR3021220B1 (fr) * 2014-05-21 2017-08-25 Air Liquide Association de xenon et d’un antioxydant pour lutter contre une maladie neurodegenerative de type maladie de parkinson
CN107921008A (zh) 2015-06-23 2018-04-17 诺比利斯治疗学公司 使用惰性气体组合物的治疗性免疫调节
US10022397B2 (en) * 2016-06-20 2018-07-17 Nobilis Therapeutics, Inc. Treatment of rheumatoid arthritis using noble gas mixtures

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
DE19933704A1 (de) 1999-07-19 2001-01-25 Michael Georgieff Verwendung einer lipophile Gase enthaltenden Präparation zur Neuroprotektion und Neuroregeneration
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) * 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
AU2001247841A1 (en) * 2000-03-31 2001-10-30 Innercool Therapies, Inc. Medical procedure
ATE380554T1 (de) * 2003-10-10 2007-12-15 Protexeon Ltd Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie

Also Published As

Publication number Publication date
WO2005034966A1 (en) 2005-04-21
AU2004280118B2 (en) 2009-01-15
US7390508B2 (en) 2008-06-24
ATE380554T1 (de) 2007-12-15
ES2298815T3 (es) 2008-05-16
MXPA06003471A (es) 2006-06-14
EP1670489B1 (en) 2007-12-12
CA2538104C (en) 2013-12-10
US20070104796A1 (en) 2007-05-10
PT1670489E (pt) 2008-02-28
DE602004010691D1 (de) 2008-01-24
JP4880466B2 (ja) 2012-02-22
EP1670489A1 (en) 2006-06-21
AU2004280118A1 (en) 2005-04-21
CA2538104A1 (en) 2005-04-21
DK1670489T3 (da) 2008-01-07
JP2007508284A (ja) 2007-04-05
DE602004010691T2 (de) 2008-12-04

Similar Documents

Publication Publication Date Title
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
ECSP045069A (es) Uso de flibanserina en el tratamiento de trastornos sexuales
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
PH12011502704A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
CR10166A (es) Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania
ECSP055964A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
GT200900319A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
EA201070195A1 (ru) ПРОИЗВОДНЫЕ 1,2,3,4-ТЕТРАГИДРОПИРРОЛО [1,2-А]ПИРАЗИН-6-КАРБОКСАМИДОВ И 2,3,4,5-ТЕТРАГИДРОПИРРОЛО [1,2-a][1,4]-ДИАЗЕПИН-7-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
GT200600409A (es) Uso de agomelatina para obtener medicamentos propuestos para el tratamiento de trastornos del sueño en el paciente deprimido.
PT1220676E (pt) Prevencao do cancro colorrectal
CY1108501T1 (el) Συνθεση δια την προληψη και θεραπευτικη αγωγη ασθενειων κρυολογηματος
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine
MX2008002456A (es) Uso de ambroxol para el tratamiento de infecciones por rinovirus.
EA200801890A1 (ru) Средство для лечения шума в ушах
BRPI0410998A (pt) derivados de indol com efeito de indução de apoptose
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
PL1818052T3 (pl) Zastosowanie formoterolu w profilaktycznym i/lub terapeutycznym leczeniu wyniszczenia mięśniowego i/lub zespołu wyniszczenia, związanych ze stanami katabolicznymi w przebiegu niektórych chorób, takich jak nowotwory, AIDS, zakażenia, cukrzyca i inne
BRPI0516832A (pt) uso para alfa-simpatomiméticos com uma estrutura de 2-imidazolina
TW200605891A (en) Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
TN2012000256A1 (en) Therapeutic use of protein-polymer conjugates

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: PROTEXEON LIMITED (GB)

B25A Requested transfer of rights approved

Owner name: IMPERIAL INNOVATIONS LIMITED (GB)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL